Montefarmaco, a privately held Italian pharmaceutical company, has acquired Jordan Tech
Kees van Ophem, executive vice president and global general counsel di Fresenius Medical Care tells MAG how since the pandemic exploded his work has changed, requiring the legal team a coordination at multiple levels: from
The acquisition will enable Roche to develop Roche v-TAC, a digital diagnostic solution that allows medical institutions to obtain results for arterial blood gas values in a simpler manner.
Idorsia, a Swiss biopharmaceutical company, completed a private placement with institutional investors of 11m new registered shares, corresponding to 8.4% of its currently issued share capital, issued out of its authorized share capital by way of
Redbiotec, a Swiss developer of a therapeutic vaccine for genital herpes, plans to close CHF 9m Series A round this year
Becton, Dickinson and Company (BD) acquired Straub Medical, a privately-held company that develops and sells medical atherectomy and thrombectomy devices that treat PAD and Venous disease.
FoRx Therapeutics, a Basel-based biotechnology company developing a new generation of cancer drugs focusing on novel DNA Replication Stress (DRS) pathways activated in cancer, completes a EUR 10M seed-financing round
Relief Therapeutics Holding announces the closing of the binding Share Exchange Agreement for the acquisition by Sonnet BioTherapeutics, now a subsidiary of Sonnet BioTherapeutics Holdings
Karo Pharma has acquired Hygis, a Swiss distributing company with exclusive distribution rights to Karo’s brands MultiGyn and MultiMam.
Centre Biologie Nord Artois (CBNA), a French biology analysis specialist, has been sold by several biologists to the Swiss clinical laboratory and medical diagnostic imaging services company Unilab
